Effect of cyclooxygenase inhibitors on gentamicin-induced nephrotoxicity in rats

Effect of cyclooxygenase inhibitors on gentamicin-induced nephrotoxicity in rats

Autor Hosaka, E.m. Google Scholar
Santos, Oscar Fernando Pavão dos Autor UNIFESP Google Scholar
Seguro, A.c. Google Scholar
Vattimo, M.f.f. Google Scholar
Instituição Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Resumo The frequent use of nonsteroidal anti-inflammatory drugs (NSAID) in combination with gentamicin poses the additional risk of nephrotoxic renal failure. Cyclooxygenase-1 (COX-1) is the main enzyme responsible for the synthesis of renal vasodilator prostaglandins, while COX-2 participates predominantly in the inflammatory process. Both are inhibited by non-selective NSAID such as indomethacin. Selective COX-2 inhibitors such as rofecoxib seem to have fewer renal side effects than non-selective inhibitors. The objective of the present study was to determine whether the combined use of rofecoxib and gentamicin can prevent the increased renal injury caused by gentamicin and indomethacin. Male Wistar rats (250-300 g) were treated with gentamicin (100 mg/kg body weight, ip, N = 7), indomethacin (5 mg/kg, orally, N = 7), rofecoxib (1.4 mg/kg, orally, N = 7), gentamicin + rofecoxib (100 and 1.4 mg/kg, respectively) or gentamicin + indomethacin (100 and 5 mg/kg, respectively, N = 8) for 5 days. Creatinine clearance and alpha-glutathione-S-transferase concentrations were used as markers of renal injury. Animals were anesthetized with ether and sacrificed for blood collection. The use of gentamicin plus indomethacin led to worsened renal function (0.199 ± 0.019 ml/min), as opposed to the absence of a nephrotoxic effect of rofecoxib when gentamicin plus rofexicob was used (0.242 ± 0.011 ml/min). These results indicate that COX-2-selective inhibitors can be used as an alternative treatment to conventional NSAID, especially in situations in which risk factors for nephrotoxicity are present.
Palavra-chave Indomethacin
Rofecoxib
Nonsteroidal anti-inflammatory drugs
Aminoglycoside
Acute renal failure
Idioma Inglês
Data de publicação 2004-07-01
Publicado em Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 37, n. 7, p. 979-985, 2004.
ISSN 0100-879X (Sherpa/Romeo, fator de impacto)
Publicador Associação Brasileira de Divulgação Científica
Extensão 979-985
Fonte http://dx.doi.org/10.1590/S0100-879X2004000700006
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000222450200006
SciELO S0100-879X2004000700006 (estatísticas na SciELO)
Endereço permanente http://repositorio.unifesp.br/handle/11600/2154

Exibir registro completo




Arquivo

Nome: S0100-879X2004000700006.pdf
Tamanho: 458.5KB
Formato: PDF
Descrição:
Abrir arquivo

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta